VRTX/VX-770 in cystic fibrosis - another smaller trial but in young children, hit its primary endpoint http://www.reuters.com/article/2011/03/29/vertex-idUSL3E7ET22Q20110329?feedType=RSS&feedName=hotStocksNews&rpc=43